Medical Network Marek Woynarowski, Jarosław Kierkuśsp. j.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2014-04-01
Registered address
ul. Płowiecka 103, 04-501 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed.
- 2023not filed
- 202208/03/2023
- 202115/06/2022
- 202028/06/2021
- 201931/03/2020
- 201831/05/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Voivodeship · Mazowieckie43,775 / 142,048
Top 31%
Country · Poland160,474 / 495,935
Top 32%
Results vs industry
Revenue
This companyUSD 522.14kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD 126.74kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 383.47kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 1.44mMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Agnieszka Maria Olekage 51 – Attorney-in-fact (sole)
Manner of representation
Each partner is independently entitled to represent the company.
Ownership
| Owner |
|---|
Jarosław Piotr Kierkuśage 59 |
Agnieszka Maria Olekage 51 |
Bank accounts
Registered as a VAT taxpayer on 2006-01-24.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $16,232.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 21, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezydent Miasta Stołecznego Warszawy | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Alcidsp. z o.o. | $1,230,813.28 | alcid.pl | ||
| WPD Pharmaceuticalssp. z o.o. | $919,175.63 | wpdpharmaceuticals.com | ||
| RDLSsp. z o.o. | $880,573.67 | rdls.pl | ||
| Ecoverseasp. z o.o. | $891,022.45 | coslab.pl | ||
| Bioresearch Groupsp. z o.o. | $776,186.19 | bioresearch.pl | ||
| Zakład Genetyki Sądowejsp. z o.o. | $727,654.12 | dna-zgs.pl | ||
| Proper Medical Writingsp. z o.o. | $514,848.41 | propermedicalwriting.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Biocloner Healthsp. z o.o. | $274,915.43 | bioclonerhealth.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-11-20 | Address change (Gedymina 28a, 04-120, Warszawa → Ul. Płowiecka 103, 04-501, Warszawa) | |
| 2017-11-20 | PKD change (Removed: 23 codes) | |
| 2014-04-01 | Entered in the register |
FAQ
The main business activity of Medical Network Marek Woynarowski, Jarosław Kierkuś focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 1, 2014.
The headquarters is located at: ul. Płowiecka 103, 04-501 Warszawa.
The legal form of this entity is a general partnership (sp.j.).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
In 2022, the company generated total revenue of USD 522,141, representing an increase of 44.0% compared to 2021.
Yes, the company recorded a net profit of USD 126,742 in 2022, representing a multi-fold increase compared to 2021.
The largest operating cost category falls under employee remuneration. This category amounted to USD 195,662 in 2022, representing 51% of all operating expenses.
Last updated: 2026-10-21
